Navigation Links
KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million
Date:6/18/2012

JERUSALEM, June 18, 2012 /PRNewswire/ -- Hadasit Bio-Holdings ("HBL") (TASE: HDST, OTC: HADSY) a publicly traded portfolio of biotech companies, based on intellectual property developed and owned by the Hadassah University Hospital, Israel's foremost medical research center, today announced that KAHR Medical Ltd. ("KAHR"), a portfolio company in which HBL and Sanofi (NYSE: SNY) hold approximately 70% and 20% respectively, will raise $2.6 million at a pre-investment valuation of $11 million.

Thomas Eldered, co-owner of Recipharm (www.recipharm.com), one of the largest pharmaceutical Contract Development and Manufacturing Organizations (CDMO) in Europe, will invest $2 million and hold approximately 15% of the company. Sanofi, the third largest pharmaceutical company in the world, will maintain its current holdings with an investment of $500,000. HBL will invest an additional $100,000 and reduce its holding in the company to approximately 55%.

Ophir Shahaf, CEO of HBL, commented on the investment round, "This investment is another significant achievement following a string of strategic agreements that we have recently closed in our portfolio companies. Forming synergistic collaborations with our partners is a major part of our strategy, and the pre-investment valuations of our recent deals reflect the recognition of value that global pharmaceutical companies give to our portfolio companies. Additional developments - clinical, scientific and strategic - are in progress and are expected to materialize in the coming months, creating substantial value for our shareholders."

Dr. Noam Shani, CEO of KAHR, stated, "We are proud of this investment agreement. I am convinced that the partnership with Mr. Eldered, co-founder and CEO of one of the leading pharmaceutical CDMOs in Europe, will bring significant benefits to KAHR. Additi
'/>"/>

SOURCE Hadasit Bio-Holdings
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. MD+DI, the Global MedTech Industry Authority, Wins a 2012 Maggie for Best Overall Category in Medical, Dental & Related Services/Trade
2. MD+DI, the Global MedTech Industry Authority, Wins a 2012 Maggie for Best Cover in the Medical, Dental & Related Services/Trade Category
3. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
4. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
5. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
6. Life Technologies Signs Licensing Agreement with iPS Academia Japan for Global Patent Portfolio Rights to Induced Pluripotent Stem Cell Technology
7. QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio
8. CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems
9. Nycomed, a Takeda Company, Launches Omnaris® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis
10. Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
11. Sangart Raises Additional $50M Series G Funding Following Interim Safety Analysis Of Phase 2b Study Of MP4OX In Severe Trauma Patients With Hemorrhagic Shock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... May 16, 2013 A new ... models, from Cole-Parmer is designed to meet the ... includes: , The new Cole-Parmer® MS-3400 Centrifuges ... in the lab. They ensure a powerful and ... specimen separation. Their standard four-place swinging buckets hold ...
(Date:5/16/2013)... Kitware , a leading ... new Phase II SBIR funding from the U.S. ... an open-source, high performance computing (HPC) simulation and ... researchers to select only the toolkits and applications ... or analysis tasks. , Manufacturers increasingly rely ...
(Date:5/16/2013)... 2013  The registration deadline has been extended until ... 2013 National Conference, the premier conference for bioscience financial ... the Hilton San Diego Bayfront. "We ... and want to make sure as many people as ... Brandi Roberts , Chief Financial Officer of Mast ...
(Date:5/16/2013)... As the weather warms, women everywhere are waiting for the ... make a statement with fashion, many change their makeup to ... mixes makeup and sweat to produce, and increase acne breakouts. ... warmer months, Adult Acne treatment , Probiotic Action shares ... to deter breakouts. , Recently, an article from ...
Breaking Biology Technology:Cole-Parmer Offers Enhanced Selection of Centrifuges 2Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2
... MONTVALE, N.J., June 26 Barr Pharmaceuticals,Inc. (NYSE: ... Court for Delaware has,ruled in favor of its ... patent listed by Boehringer Ingelheim Pharmaceuticals, Inc. in,connection ... 0.5mg, 1mg & 1.5mg., In his ruling, ...
... will be home to the,world,s first industrial scale ... City has signed a 25-year agreement with GreenField,Ethanol, ... biofuels,technology company., The $70 million biofuels facility ... year and reduce Alberta,s carbon dioxide (CO2),footprint by ...
... Balance Business Benefits with ... Environmental Responsibility, FALLS CHURCH, Va., and ATLANTA, ... constrained by the,inability to justify cost of implementation, according to "The ... CSC ), Manhattan,Associates Inc. (Nasdaq: MANH ), IBM and ...
Cached Biology Technology:Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 2Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 3Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 4Edmonton to be site of world's first industrial scale municipal waste-to-ethanol facility 2Edmonton to be site of world's first industrial scale municipal waste-to-ethanol facility 3Edmonton to be site of world's first industrial scale municipal waste-to-ethanol facility 4Edmonton to be site of world's first industrial scale municipal waste-to-ethanol facility 5Study Reveals Greatest Barrier to Green Supply Chain Initiatives 2Study Reveals Greatest Barrier to Green Supply Chain Initiatives 3
(Date:5/18/2013)... Research presented at Digestive Disease Week (DDW) ... diet and lifestyle. , Individuals suffering from ... strength, fatigue and poor quality of life. These ... remission. A randomized, double blind, placebo-controlled study found ... corresponded to significant relief of these symptoms. ...
(Date:5/17/2013)... University of New Jersey, and City University of New ... TM that effectively clears organisms to be viewed ... chloral hydrate, which is one of the few high-quality ... by the Drug Enforcement Administration (DEA) due to its ... agents, are vital for viewing organisms under a microscope. ...
(Date:5/17/2013)... Efficient and Sustainable Global Logistics Operations) is aiming to ... efficiency of intermodal loading systems and the boosting of ... European organisations with experience in the logistics sector and ... 17,000,000 and a duration of three and a half ... the semantic components and ontologies shared by the users, ...
Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3New logistics services that will cut energy consumption and CO2 emissions 2
... Humans have an innate defence system against deadly bacteria. However, ... the body is not yet known. To date, B. ... elude medics. It can remain hidden in the human body ... The bacteria can suddenly become activated and spread throughout the ...
... LUNG TRANSPLANTATION , (Tuesday, October 28, 10:30 AM ... arrhythmias, including atrial fibrillation. Researchers from Baylor College ... all lung transplant recipients in 2006 and 2007. ... 38 percent developed arrhythmias within 30 days of ...
... published in the open access journal PLoS Biology, ... surprising result that the survival of juvenile salmon in ... of an extensive network of dams in one river system., ... dwellers such as sharks, sturgeon, tuna and sea turtles, and ...
Cached Biology News:New cardiology research presented at CHEST 2008 2New cardiology research presented at CHEST 2008 3New cardiology research presented at CHEST 2008 4Research challenges conventional notions about salmon survival 2